Comparison of the efficacy of Atorvastatin and Rosuvastatin in atrial fibrillation incidence after coronary artery bypass graft surgery (CABG)

Phase 2

• Conditions: Condition 1: Atrial fibrillation after CABG. Condition 2: Atrial fibrillation after CABG.; Unspecified complication of cardiac and vascular prosthetic device, implant and graft; T82.9; I48.0; Paroxysmal atrial fibrillation

• Registration Number: IRCT20201028049175N2
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 104

Inclusion Criteria

All of patients reffered to Amiralmomenin hospital for elective CABG surgery
Patients with 40 or more than 40 EF
Patients with On-pump method in surgery

Exclusion Criteria

Recent MI
Using of antiarhythmic drugs especially Amiodarone
History of AF
Valvular dysfunction
Other surgeries with CABG
Organic disease (i.e chronic renal failure stage 3 and 4), thyroid dysfunction, immunosuppression, cancer, central nervous system disease, brain vessels disease and history of CerebroVascular Accident, hormonal diseases, rise of liver enzymes)
Hypo/hyperkalemia
Dialysis (abnormal Cr)
Use of anti-inflammatory drugs
Psychological disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of post CABG atrial fibrillation. Timepoint: As starting drug till 7 days after surgery. Method of measurement: Heart monitoring.